Emily Lin

3.5k total citations · 1 hit paper
18 papers, 2.7k citations indexed

About

Emily Lin is a scholar working on Molecular Biology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Emily Lin has authored 18 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Emily Lin's work include RNA Interference and Gene Delivery (2 papers), Respiratory Support and Mechanisms (2 papers) and MicroRNA in disease regulation (2 papers). Emily Lin is often cited by papers focused on RNA Interference and Gene Delivery (2 papers), Respiratory Support and Mechanisms (2 papers) and MicroRNA in disease regulation (2 papers). Emily Lin collaborates with scholars based in United States, Taiwan and Australia. Emily Lin's co-authors include Erin L. McDearmon, Robert H. Eckel, Amy Easton, Dalan R. Jensen, Aaron D. Laposky, Joseph Bass, Corinne E. Joshu, Joseph S. Takahashi, Fred W. Turek and Akira Kohsaka and has published in prestigious journals such as Science, Journal of Biological Chemistry and Scientific Reports.

In The Last Decade

Emily Lin

18 papers receiving 2.7k citations

Hit Papers

Obesity and Metabolic Syndrome in Circadian Clock Mutant ... 2005 2026 2012 2019 2005 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Lin United States 13 1.6k 1.2k 506 318 259 18 2.7k
Tami A. Martino Canada 31 1.6k 1.0× 1.1k 0.9× 557 1.1× 384 1.2× 190 0.7× 61 2.8k
Xiaozhong Wang China 22 1.1k 0.7× 895 0.7× 614 1.2× 238 0.7× 855 3.3× 66 2.9k
Marina Maria Bellet Italy 22 1.1k 0.7× 834 0.7× 718 1.4× 245 0.8× 171 0.7× 56 2.4k
Xuan Zhao China 18 826 0.5× 577 0.5× 860 1.7× 197 0.6× 93 0.4× 34 2.0k
Michèle Teboul France 24 1.1k 0.7× 1.2k 1.0× 1.1k 2.1× 206 0.6× 542 2.1× 54 3.2k
María Elena Díaz-Casado Spain 19 917 0.6× 429 0.3× 762 1.5× 88 0.3× 170 0.7× 31 2.0k
Johanna L. Barclay Australia 23 638 0.4× 658 0.5× 298 0.6× 75 0.2× 183 0.7× 41 1.6k
M. D. Mediavilla Spain 26 1.6k 1.0× 461 0.4× 509 1.0× 87 0.3× 47 0.2× 43 2.3k
Moisés Alejandro Alatorre-Jiménez United States 10 861 0.5× 381 0.3× 509 1.0× 73 0.2× 105 0.4× 27 2.0k
Carolina Doerrier Spain 18 792 0.5× 394 0.3× 773 1.5× 94 0.3× 152 0.6× 34 1.8k

Countries citing papers authored by Emily Lin

Since Specialization
Citations

This map shows the geographic impact of Emily Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Lin more than expected).

Fields of papers citing papers by Emily Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Lin. The network helps show where Emily Lin may publish in the future.

Co-authorship network of co-authors of Emily Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Lin. A scholar is included among the top collaborators of Emily Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Lin. Emily Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hsu, Chih–Yuan, Emily Lin, & Yu Shyr. (2021). Development and Evaluation of a Method to Correct Misinterpretation of Clinical Trial Results With Long-term Survival. JAMA Oncology. 7(7). 1041–1041. 10 indexed citations
2.
Wang, Mai, Emily Lin, Li‐Ching Huang, et al.. (2020). Mortality of Cardiovascular Events in Patients With COPD and Preceding Hospitalization for Acute Exacerbation. CHEST Journal. 158(3). 973–985. 32 indexed citations
3.
Baiocchi, Leonardo, Nan Wu, Burcin Ekser, et al.. (2020). Kupffer Cells. American Journal Of Pathology. 190(11). 2185–2193. 107 indexed citations
4.
Lai, Wei‐Yun, et al.. (2019). A Novel TNF-α-Targeting Aptamer for TNF-α-Mediated Acute Lung Injury and Acute Liver Failure. Theranostics. 9(6). 1741–1751. 110 indexed citations
5.
Roberts, Emily, Maryann Shango, Brian G. Till, et al.. (2019). Multicentre retrospective study of intravascular large B‐cell lymphoma treated at academic institutions within the United States. British Journal of Haematology. 186(2). 255–262. 17 indexed citations
6.
Lin, Emily, Fabien B. Vincent, Joanne Sahhar, et al.. (2019). Analysis of serum interleukin(IL)‐1α, IL‐1β and IL‐18 in patients with systemic sclerosis. Clinical & Translational Immunology. 8(4). e1045–e1045. 24 indexed citations
7.
Vincent, Fabien B., Rangi Kandane‐Rathnayake, Rachel Koelmeyer, et al.. (2018). Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus. Frontiers in Immunology. 9. 1250–1250. 92 indexed citations
8.
Vincent, Fabien B., Emily Lin, Joanne Sahhar, et al.. (2018). Analysis of serum macrophage migration inhibitory factor and D‐dopachrome tautomerase in systemic sclerosis. Clinical & Translational Immunology. 7(12). e1042–e1042. 14 indexed citations
9.
Lin, Emily, Tzu-Hung Hsiao, Tzu‐Pin Lu, et al.. (2018). Translating Gene Signatures Into a Pathologic Feature: Tumor Necrosis Predicts Disease Relapse in Operable and Stage I Lung Adenocarcinoma. JCO Precision Oncology. 2(2). 1–13. 8 indexed citations
10.
Lin, Emily, Ching‐Heng Lin, Ching‐Yao Yang, et al.. (2018). Population-Based Cohort Study Reveals Distinct Associations Between Female Lung Cancer and Breast Cancer in Taiwan. JCO Clinical Cancer Informatics. 2(2). 1–14. 9 indexed citations
11.
Lai, Wei‐Yun, et al.. (2017). A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect. Molecular Therapy — Nucleic Acids. 8. 520–528. 55 indexed citations
12.
Anand, Prachi, Alison O’Neil, Emily Lin, Trevor Douglas, & Mandë Holford. (2015). Tailored delivery of analgesic ziconotide across a blood brain barrier model using viral nanocontainers. Scientific Reports. 5(1). 12497–12497. 56 indexed citations
13.
Han, Yuyan, Kelly McDaniel, Tianhao Zhou, et al.. (2015). Functional Role of Cellular Senescence in Biliary Injury. American Journal Of Pathology. 185(3). 602–609. 47 indexed citations
14.
McDaniel, Kelly, Tianhao Zhou, Heather Francis, et al.. (2014). The functional role of microRNAs in alcoholic liver injury. Journal of Cellular and Molecular Medicine. 18(2). 197–207. 96 indexed citations
15.
Yang, Ruojing, Denise M. Wilcox, Deanna L. Haasch, et al.. (2007). Liver-specific Knockdown of JNK1 Up-regulates Proliferator-activated Receptor γ Coactivator 1β and Increases Plasma Triglyceride despite Reduced Glucose and Insulin Levels in Diet-induced Obese Mice. Journal of Biological Chemistry. 282(31). 22765–22774. 51 indexed citations
16.
Wilcox, Denise M., Ruojing Yang, Sherry J. Morgan, et al.. (2006). Delivery of RNAi reagents in murine models of obesity and diabetes.. Europe PMC (PubMed Central). 8 indexed citations
17.
Bush, Eugene N., Robin Shapiro, Michael E. Brune, et al.. (2006). Chronic Treatment with Either Dexfenfluramine or Sibutramine in Diet-Switched Diet-Induced Obese Mice. Endocrine. 29(2). 375–382. 9 indexed citations
18.
Turek, Fred W., Corinne E. Joshu, Akira Kohsaka, et al.. (2005). Obesity and Metabolic Syndrome in Circadian Clock Mutant Mice. Science. 308(5724). 1043–1045. 1961 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026